Cargando…
Rifampicin Mono-Resistant Tuberculosis—A Review of an Uncommon But Growing Challenge for Global Tuberculosis Control
Tuberculosis (TB) remains the leading cause of death by an infectious pathogen worldwide, and drug-resistant TB is a critical and rising obstacle to global control efforts. Most scientific studies and global TB efforts have focused on multidrug-resistant TB (MDR-TB), meaning isolates resistant to bo...
Autores principales: | Malenfant, Jason H, Brewer, Timothy F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7888568/ https://www.ncbi.nlm.nih.gov/pubmed/33623803 http://dx.doi.org/10.1093/ofid/ofab018 |
Ejemplares similares
-
Should treatment of low-level rifampicin mono-resistant tuberculosis be different?
por: Gopie, F.A., et al.
Publicado: (2021) -
Should treatment of low-level rifampicin mono-resistant tuberculosis be different?
por: Van Deun, Armand, et al.
Publicado: (2021) -
Rifampicin mono-resistant tuberculosis in France: a 2005–2010 retrospective cohort analysis
por: Meyssonnier, Vanina, et al.
Publicado: (2014) -
Management of rifampicin mono‐resistant tuberculosis in Queensland, Australia: a retrospective case series
por: Gibson, Justine, et al.
Publicado: (2018) -
Prevalence, Risk Factors, and Treatment Outcomes of Isoniazid- and Rifampicin- Mono-Resistant Pulmonary Tuberculosis in Lima, Peru
por: Villegas, Leonela, et al.
Publicado: (2016)